Facilitating strategic connections
that drive life science dealmaking.
8 Global events
11,644 Executive-level attendees attracted
48,347 One-to-one partnering meetings held
6,673 Attending companies
60 Countries represented
12,193 Licensing opportunities on offer
In honor of BIO-Europe’s 25th anniversary, this new e-book highlights the evolution of the European biotech sector. Inside you will find an interview with EBD's founder Carola Schropp, as she reflects on BIO-Europe’s role in the development of European biotech, a timeline of key events that have shaped the sector, as well as a dip into the Informa Pharma Intelligence archive.
What does it take to launch a successful biotech company? This sourcebook gathers advice from some of the industry’s best sources to help entrepreneurs solve some of the toughest—and often unexpected—challenges of creating a life sciences startup.
Ninety-five percent of VCs add zero value to a startup other than cash, said tech venture capitalist Vinod Khosla. He explained that about four out of every five VCs actually damage their own investments with bad advice.
So who out there is more than just a checkbook? Which VCs bring value to the table, in the form of useful introductions or strategy?
We consistently provide valuable in-depth insight and analysis on the most recent trends in life science and partnering. Don't miss the latest releases!
partneringONE is even more powerful than before. New features and functionality will increase your productivity and improve your partnering experience. Look out for a mobile-responsive platform, time-saving message templates and enhanced search capabilities and collaboration tools.
FIND OUT MORE
Our network of more than 40,000 high-value dealmakers, companies and assets from around the world are looking for "best-fit" partners.
Find out more© 2008- 2019 EBD GmbH/EBD Group
EBD Group is part of
is an Informa business